Sobi’s presentations highlight research across multiple rare diseases in haematology including PNH, ITP, HLH and myelofibrosis.STOCKHOLM, June 11, 2026 /PRNewswire/ — Sobi (STO: SOBI) today annou…
Swedish Orphan Biovitrum AB: Sobi to present new clinical and real-world data at EHA 2026 in Stockholm
Source: Finanznachrichten.de
Read Full Story →
